NYSE · CNC
Healthcare · Medical - Healthcare Plans
$65.36
Up+$0.82 (+1.27%)
Updated Oct 10, 2026, 7:14 PM
SID Score
6.4/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CNC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
CNC closed at $65.36 after 21 trading sessions, down 1.60% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $64.67 | $67.39 | $64.45 | $65.36 | 2.85M |
| Oct 8, 2026 | $64.84 | $65.32 | $63.35 | $64.54 | 3.95M |
| Oct 7, 2026 | $64.52 | $66.18 | $63.953 | $64.99 | 5.22M |
| Oct 6, 2026 | $64.24 | $64.76 | $63.605 | $64.61 | 3.66M |
| Oct 5, 2026 | $63.01 | $64.34 | $62.93 | $64.30 | 4.54M |
| Oct 2, 2026 | $61.00 | $63.36 | $60.75 | $62.99 | 3.58M |
| Oct 1, 2026 | $61.82 | $62.29 | $59.46 | $60.99 | 5.3M |
| Sep 30, 2026 | $62.23 | $62.69 | $60.94 | $62.12 | 3.64M |
| Sep 29, 2026 | $61.85 | $62.42 | $61.38 | $62.21 | 4.27M |
| Sep 28, 2026 | $62.49 | $63.40 | $61.72 | $62.53 | 5.17M |
| Sep 25, 2026 | $62.09 | $63.67 | $61.73 | $61.82 | 3.63M |
| Sep 24, 2026 | $62.16 | $62.84 | $61.25 | $61.92 | 4.57M |
| Sep 23, 2026 | $63.29 | $63.67 | $61.87 | $62.08 | 3.42M |
| Sep 22, 2026 | $64.88 | $65.30 | $62.48 | $63.30 | 6.1M |
| Sep 21, 2026 | $65.19 | $65.58 | $64.56 | $64.99 | 4.42M |
| Sep 18, 2026 | $66.89 | $67.73 | $65.03 | $65.11 | 13.45M |
| Sep 17, 2026 | $66.63 | $67.79 | $65.76 | $67.10 | 5.13M |
| Sep 16, 2026 | $68.40 | $69.41 | $66.01 | $66.01 | 4.28M |
| Sep 15, 2026 | $68.50 | $68.62 | $67.05 | $67.66 | 3.58M |
| Sep 14, 2026 | $67.31 | $69.63 | $67.15 | $69.41 | 4.1M |
| Sep 11, 2026 | $65.70 | $66.85 | $64.52 | $66.42 | 3.63M |
The latest Smart Investors Daily articles mentioning CNC.
Company
Market Activity
Research & News
CNC research
Company profile and research snapshot.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 11, 2026 | Argus Research | Buy | — |
| Aug 4, 2026 | JP Morgan | Neutral | — |
| Aug 3, 2026 | Bernstein | Outperform | — |
| Jul 29, 2026 | Barclays | Overweight | — |
| Jul 29, 2026 | Baird | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 1, 2026
Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%. Growth stocks outperformed value, although value retained a year-to-date lead. The market’s rise was fueled […]
Yahoo · Oct 1, 2026
TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the “TCW Relative Value Mid Cap Fund”. The letter can be downloaded here. Equities advanced in Q2 2026, with the S&P 500 reaching record highs despite volatility from a Federal Reserve leadership transition and Middle East tensions. Markets rebounded from Q1 lows, […]
Yahoo · Oct 1, 2026
Wellcare, the Medicare brand of Centene Corporation (NYSE: CNC), today announced its 2027 Medicare Advantage (MA) and Prescription Drug Plan (PDP) offerings ahead of the Medicare Annual Enrollment Period (AEP), which begins Oct. 15 and runs through Dec. 7.
Yahoo · Sep 29, 2026
UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CNC.
